Salivary Gland Removal — Procedure Guide, Recovery & Risks | MyMedicPlus
Quick Facts
What Is Salivary Gland Removal?
Salivary gland removal (sialoadenectomy) surgically excises a major salivary gland: the parotid (largest), submandibular, or sublingual gland. Parotidectomy is most common, performed as superficial (lateral to facial nerve) or total (deep and superficial lobes) depending on tumor location.
Who Needs This Procedure?
Indications include benign neoplasms (pleomorphic adenoma, Warthin tumor), malignant salivary gland tumors (mucoepidermoid, adenoid cystic carcinoma), recurrent parotitis, chronic sialolithiasis (stones) not amenable to lithotripsy or endoscopy, and salivary fistula.
How the Procedure Is Performed
Under general anaesthesia, a pre-auricular and cervical incision exposes the parotid gland. The facial nerve (CN VII) is identified at the stylomastoid foramen and traced forward; the superficial lobe is removed preserving all branches. Submandibular removal uses a 4 cm neck incision, protecting the marginal mandibular nerve and lingual nerve.
Recovery & Aftercare
Hospital stay is 1-2 days; drains are removed within 24-48 hours. A soft diet is recommended for 2 weeks. Sutures are removed at 7-10 days. Swelling and stiffness improve over 2-3 weeks. Frey syndrome (gustatory sweating) may develop weeks to months post-operatively.
Risks & Complications
Temporary facial nerve weakness occurs in up to 20% of parotidectomy patients; permanent palsy is below 2% with careful nerve dissection. Frey syndrome (sweating while eating) affects 15-30% of patients. Other risks include dry mouth, wound infection, hematoma, and salivary fistula.
Results & Success Rates
Cure rates exceed 95% for benign tumors with clear margins. Recurrence of pleomorphic adenoma after enucleation (without parotidectomy) is up to 20%; proper parotidectomy reduces recurrence below 2%. 5-year survival for low-grade malignant salivary tumors exceeds 80% with adequate resection.
Frequently Asked Questions
References
- McGurk M et al. Salivary Gland Disorders. Springer. 2007.
- British Association of Head and Neck Oncologists — Salivary Gland Tumor Guidelines, 2024
- AAOHNS — Sialendoscopy and Salivary Gland Surgery Position Statement, 2025
Medically Reviewed
Our medical content follows strict editorial guidelines to ensure accuracy and reliability.
Up to Date
Last updated: 2026-06-26
Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.
Ready to take the next step?
Connect with top hospitals and specialists. Get personalized guidance for your medical journey.